|
Preclinical |
Phase I |
Phase II* |
Phase III |
Marketed |
| |
|
|
|
|
|
| Hypogonadism: |
|
|
|
|
|
Testim®
Auxilium |
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
| Urology: |
|
|
|
|
|
Nocturia**
Serenity |
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
| Diabetes: |
|
|
|
|
|
Nasulin™
CPEX |
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
| Other Areas: |
|
|
|
|
|
Undisclosed
Various |
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
| |
|
|
|
|
|
*
** |
Strategic
goal to partner internal products after Phase II
Source: clinicaltrials.gov web site |
